DR.LAL Path LABDR. Lal Path Lab
Trendline Breakout With Good Volume
RSI Above 60
Price Close Above EMA
Buy :- 3208
SL :- 2985
Target :- 3309 / 3356 / 3505 / 3605
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
48.25 INR
3.58 B INR
22.27 B INR
37.18 M
About DR. LAL PATH LABS LTD.
Sector
Industry
CEO
Shankha Banerjee
Website
Headquarters
Gurgaon
Founded
1949
ISIN
INE600L01024
FIGI
BBG009WQGFD2
Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. It also involves in providing diagnostic and healthcare tests and services. The company was founded by S. K. Lal in 1949 and is headquartered in Gurgaon, India.
DR. LAL PATH LABS LTD S/RSupport and Resistance Levels:
Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
lalpathlab buy swing /pos
now at 3329 buy near 3285
avg at 3250
sl 3215 2-3%
tgt 4%8%12%16%
buy near means 10+or- consider boz buyers zone
Dr Lal Pathlab (weekly Chart)Dr Lal Pathlab (weekly Chart)
Cup & Handle Pattern
Support 2767
Expected Level 3625 / 4245
RSI above 60 Daily / Weekly / Monthly
Volume Growth
PARMA / IT / FMCG / AUTO will continue to perform
Dr. Lal Path Lab Strong Bullish Momentum, Eyeing ₹3600On the weekly chart, Dr. Lal Path Lab stock is exhibiting a strong bullish trend, with solid upward momentum pushing the stock higher. Based on multiple RSI indicators, the stock remains above 60, signaling continued strength in the trend and positive buying pressure.
Key Technical Insights:
The
LALPATHLAB bullish flag buy side lalpathlab formed bullish flag on buy side. expecting good target. let's see
50 SMA Rising - Positional TradeDisclaimer: I am not a Sebi registered adviser.
This Idea is publish purely for educational purpose only before investing in any stocks please take advise from your financial adviser.
Its 50 SMA Rising Strategy. Suitable for Positional Trading Initial Stop loss lowest of last 2 candles and keep tra
Dr. Lal Path Labs Ltd. (NSE: LALPATH) - Daily Chart with FibonacThis chart illustrates a bullish breakout pattern in Dr. Lal Path Labs Ltd. on the NSE, analyzed on the daily time frame.
Key Technicals:
Fibonacci Levels: The Fibonacci extension tool is applied from the recent swing low around ₹3,278.85 to the swing high at ₹3,558.65.
1.618 Extension: ₹3,731.75
2
LALPATHLAB - Long Above 2600LALPATHLAB - Can go Long above 2600 for half quantity and full quantity good candle close above 2700
In consolidation for last 2 years and inverse head and shoulder pattern in Weekly timeframe.
Stoploss - Mentioned in the Chart.
Target - TP1 and TP2 mentioned in the Chart.
Momentum Trading Picks - Dr.Lal Path LabsAs the chart clearly shows a breakout with the significant volume on a monthly time frame it's clear that we can see the great opportunity in the long side and since the market and sector both are in a bullish phase we can see the target will be achieved in no time.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LALPATHLAB is 2,924.15 INR — it has decreased by −0.75% in the past 24 hours. Watch DR. LAL PATH LABS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange DR. LAL PATH LABS LTD. stocks are traded under the ticker LALPATHLAB.
LALPATHLAB stock has fallen by −1.70% compared to the previous week, the month change is a −2.99% fall, over the last year DR. LAL PATH LABS LTD. has showed a 12.43% increase.
We've gathered analysts' opinions on DR. LAL PATH LABS LTD. future price: according to them, LALPATHLAB price has a max estimate of 3,770.00 INR and a min estimate of 2,461.00 INR. Watch LALPATHLAB chart and read a more detailed DR. LAL PATH LABS LTD. stock forecast: see what analysts think of DR. LAL PATH LABS LTD. and suggest that you do with its stocks.
LALPATHLAB reached its all-time high on Sep 15, 2021 with the price of 4,245.50 INR, and its all-time low was 696.50 INR and was reached on Jan 20, 2016. View more price dynamics on LALPATHLAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LALPATHLAB stock is 1.50% volatile and has beta coefficient of 0.66. Track DR. LAL PATH LABS LTD. stock price on the chart and check out the list of the most volatile stocks — is DR. LAL PATH LABS LTD. there?
Today DR. LAL PATH LABS LTD. has the market capitalization of 244.50 B, it has decreased by −4.06% over the last week.
Yes, you can track DR. LAL PATH LABS LTD. financials in yearly and quarterly reports right on TradingView.
DR. LAL PATH LABS LTD. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
LALPATHLAB earnings for the last quarter are 15.50 INR per share, whereas the estimation was 14.85 INR resulting in a 4.38% surprise. The estimated earnings for the next quarter are 11.76 INR per share. See more details about DR. LAL PATH LABS LTD. earnings.
DR. LAL PATH LABS LTD. revenue for the last quarter amounts to 6.60 B INR, despite the estimated figure of 6.69 B INR. In the next quarter, revenue is expected to reach 6.00 B INR.
LALPATHLAB net income for the last quarter is 1.29 B INR, while the quarter before that showed 1.06 B INR of net income which accounts for 21.43% change. Track more DR. LAL PATH LABS LTD. financial stats to get the full picture.
DR. LAL PATH LABS LTD. dividend yield was 0.80% in 2023, and payout ratio reached 41.82%. The year before the numbers were 0.66% and 41.63% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 4.10 K employees. See our rating of the largest employees — is DR. LAL PATH LABS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. LAL PATH LABS LTD. EBITDA is 6.58 B INR, and current EBITDA margin is 27.83%. See more stats in DR. LAL PATH LABS LTD. financial statements.
Like other stocks, LALPATHLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. LAL PATH LABS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. LAL PATH LABS LTD. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. LAL PATH LABS LTD. stock shows the buy signal. See more of DR. LAL PATH LABS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.